Erasmus Smit

Dr. Erasmus Smit

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2021 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
MBMathew A. Beale
Mathew A. Beale
MMMichael Marks
Michael Marks
MCMichelle J. Cole
Michelle J. Cole
MLMin-Kuang Lee
Min-Kuang Lee
RPRachel Pitt
Rachel Pitt
NTNicholas R. Thomson
Nicholas R. Thomson
Syphilis, which is caused by the sexually transmitted bacterium Treponema pallidum subsp. pallidum , has an estimated 6.3 million cases worldwide per annum. In the past ten years, the incidence of syphilis has increased by more than 150% in some high-income countries, but the evolution and epidemiology of the epidemic are poorly understood. To characterize the global population structure of T. pallidum , we assembled a geographically and temporally diverse collection of 726 genomes from 626 clinical and 100 laboratory samples collected in 23 countries. We applied phylogenetic analyses and clustering, and found that the global syphilis population comprises just two deeply branching lineages, Nichols and SS14. Both lineages are currently circulating in 12 of the 23 countries sampled. We subdivided T. p. pallidum into 17 distinct sublineages to provide further phylodynamic resolution. Importantly, two Nichols sublineages have expanded clonally across 9 countries contemporaneously with SS14. Moreover, pairwise genome analyses revealed examples of isolates collected within the last 20 years from 14 different countries that had genetically identical core genomes, which might indicate frequent exchange through international transmission. It is striking that most samples collected before 1983 are phylogenetically distinct from more recently isolated sublineages. Using Bayesian temporal analysis, we detected a population bottleneck occurring during the late 1990s, followed by rapid population expansion in the 2000s that was driven by the dominant T. pallidum sublineages circulating today. This expansion may be linked to changing epidemiology, immune evasion or fitness under antimicrobial selection pressure, since many of the contemporary syphilis lineages we have characterized are resistant to macrolides.

1 September 2012 in Journal of Clinical Virology
Verified
Journal Article
Closed access
BOB. Olowokure
B. Olowokure
OOO. Odedere
O. Odedere
AEAlex J Elliot
Alex J Elliot
AAA. Awofisayo
A. Awofisayo
ESErasmus Smit
Erasmus Smit
HOH. Osman
H. Osman

1 January 2021 in IDCases
Verified
Journal Article
Open access
SFShivani Fox-Lewis
Shivani Fox-Lewis
AFAndrew Fox-Lewis
Andrew Fox-Lewis
JHJay Harrower
Jay Harrower
RCRichard Chen
Richard Chen
JWJing Wang
Jing Wang
ESErasmus Smit
Erasmus Smit
We describe three cases with viral strains that demonstrate impaired N2-gene detection on the Cepheid Xpert Xpress SARS-CoV-2 assay, with two previously undescribed single nucleotide polymorphisms (SNPs): C29197T and G29227T. We propose that these SNPs are likely responsible since they are in close proximity to the previously described C29200T/C29200A SNPs, already shown to abolish N2-gene detection by the Xpert assay. Whether these SNPs abolish N2-gene detection by the Xpert assay individually or only in combination requires more work to elucidate.

Verified
Journal Article
Open access
PDF file
CLCourtney Rebecca Hamblyn Lynch
Courtney Rebecca Hamblyn Lynch
RDRevel SM Drummond
Revel SM Drummond
LJLauren Jelley
Lauren Jelley
LBLauren Ellyse Baker
Lauren Ellyse Baker
ESErasmus Smit
Erasmus Smit
CBCraig Billington
Craig Billington
Resource-limited settings and supply chain difficulties faced throughout the COVID-19 pandemic prompted the development of rapid and alternative methods of detecting SARS-CoV-2. These methods include reverse-transcription loop-mediated isothermal amplification (RT-LAMP), reverse-transcription recombinase polymerase amplification (RT-RPA), and CRISPR-Cas12a fluorescence detection. We describe RT-LAMP, RT-RPA, and CRISPR-Cas12a assays for the detection of the N and E-gene amplicons of SARS-CoV-2 and the optimization of various assay components, including incubation temperatures, Cas12a enzymes, reporter molecules, and the use of a lyophilized RT-LAMP master mix. We also describe the testing of a one-tube RT-LAMP-CRISPR-Cas12a assay. The one-tube assay showed promise in reducing hands-on time and improving time-to-result. We found no improvements in assay sensitivity with RT-RPA, but did achieve detection at a lower copy number with the lyophilized RT-LAMP master mix compared to liquid reagent (50 vs. 100 copies at 20 min). When used to detect the presence of SARS-CoV-2 RNA in clinical saliva samples from 75 infected patients, the discriminatory ability of the optimized RT-LAMP-CRISPR Cas12a assay was found to be comparable with RT-qPCR, with a minor reduction in sensitivity.

1 August 2021 in Pathology
Verified
Journal Article
Closed access
ACAlyson Craigie
Alyson Craigie
RMReuben McGregor
Reuben McGregor
AWAlana L. Whitcombe
Alana L. Whitcombe
LCLauren Carlton
Lauren Carlton
DHDavid Harte
David Harte
AUArlo Upton
Arlo Upton

22 April 2026 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
MMMatthew J Moeser
Matthew J Moeser
OCOlivia D Council
Olivia D Council
NLNathan Long
Nathan Long
LKLaura Kincer
Laura Kincer
ADAnn M Dennis
Ann M Dennis
SJSarah Joseph
Sarah Joseph
Background: HIV-1 RNA typically declines rapidly after initiation of antiretroviral therapy (ART), often reaching undetectable levels within a few weeks and remaining undetectable by standard assays. However, some patients receiving ART have persistent nonsuppressible viremia (NSV) that does not respond to treatment optimization or intensification. NSV can emerge at the time of ART initiation (primary NSV) or after being ART suppressed (secondary NSV). Here, we examine mechanisms producing primary NSV in 4 people undergoing ART. Methods: Blood samples were collected from 4 participants with advanced immunodeficiency who, despite being adherent to ART, required approximately a year or more to become virologically suppressed. Viral RNA and proviral DNA genomes were sequenced to examine HIV drug resistance, genome intactness, and genetic diversity. The ability of HIV Envs to facilitate efficient entry into cells expressing low levels of CD4, a proxy for macrophage tropism, was also assessed. Results: Before ART, blood contained HIV RNA genomes that were adapted to replication in CD4+ T cells and rapidly decayed after ART initiation. During ART, blood contained HIV genomes that were drug sensitive, genetically diverse, and macrophage tropic; moreover, they were not evolving and often had vpr defects. Conclusions: Our results suggest that in individuals with primary NSV, ART stopped virus replication, but large pools of long-lived HIV-infected macrophage continued to produce virus. This is mechanistically distinct from secondary NSV produced by CD4+ T-cell clones. Defects in vpr independently accumulated in macrophage-tropic lineages found in 3 participants, suggesting that vpr may affect survival or virus production from HIV-infected macrophage.